Review
Published on 23 Mar 2023
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1004795
- 38,541 views
- 68 citations
Type at least 3 characters
1,371 articles
Original Research
Published on 22 Mar 2023
Microglial immune regulation by epigenetic reprogramming through histone H3K27 acetylation in neuroinflammation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1052925
- 8,090 views
- 18 citations
Original Research
Published on 21 Mar 2023
Autoimmune encephalitis with mGluR5 antibodies: A case series from China and review of the literature
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1146536
- 7,035 views
- 12 citations
Mini Review
Published on 17 Mar 2023
The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1137635
- 6,976 views
- 19 citations
Editorial
Published on 16 Mar 2023
Editorial: Exploiting new methods to study microglia in healthy and diseased retina
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1177065
- 1,097 views
Case Report
Published on 14 Mar 2023
Cyclophosphamide-induced seizures in a patient with neuropsychiatric systemic lupus erythematosus (NPSLE): A case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1122629
- 3,229 views
- 4 citations
Original Research
Published on 09 Mar 2023
Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1095966
- 3,087 views
- 2 citations
Original Research
Published on 09 Mar 2023
Meningoencephalitis associated with GAD65 autoimmunity
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1120894
- 3,863 views
- 5 citations
Original Research
Published on 09 Mar 2023
Enriched environment remodels the central immune environment and improves the prognosis of acute ischemic stroke in elderly mice with chronic ischemia
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1114596
- 3,042 views
- 10 citations
Original Research
Published on 07 Mar 2023
Cladribine treatment specifically affects peripheral blood memory B cell clones and clonal expansion in multiple sclerosis patients
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1133967
- 3,922 views
- 14 citations
Brief Research Report
Published on 03 Mar 2023
Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1090548
- 4,454 views
- 5 citations
Original Research
Published on 02 Mar 2023
Knowledge mapping of global trends for myasthenia gravis development: A bibliometrics analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1132201
- 7,286 views
- 16 citations
Review
Published on 24 Feb 2023
Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1141601
- 16,020 views
- 52 citations
Brief Research Report
Published on 21 Feb 2023
Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.952911
- 1,715 views
Original Research
Published on 17 Feb 2023
Rs205764 and rs547311 in linc00513 may influence treatment responses in multiple sclerosis patients: A pharmacogenomics Egyptian study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1087595
- 2,771 views
- 2 citations
Review
Published on 15 Feb 2023
Guillain-Barre syndrome following COVID-19 vaccines: A review of literature
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1078197
- 12,386 views
- 19 citations